Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Lapatinib in Metastatic Breast Cancer Resistant to Hormone Therapy

This study has been terminated.
(slow accrual)
University of Colorado, Denver
North Shore University Hospital
Information provided by (Responsible Party):
Dartmouth-Hitchcock Medical Center Identifier:
First received: September 22, 2005
Last updated: January 12, 2015
Last verified: August 2013
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2011
  Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)